Congenital complete heart block and maternal connective tissue disease

International Journal of Cardiology

Volumn 112, Issue 2, 2006, Pages 153-158

  Jayaprasad, N ^a   Johnson, Francis ^a   Venugopal, K ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Autoantibody; Congenital Complete Heart Block; Neonatal lupus; Pacemaker; QT prolongation

Indexed keywords

AUTOANTIBODY; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DEXAMETHASONE; ISOPRENALINE; LA ANTIBODY; RITODRINE; RO ANTIBODY; SALBUTAMOL; STEROID; TERBUTALINE;

APOPTOSIS; ARRHYTHMOGENESIS; ARTIFICIAL HEART PACEMAKER; ASCITES; ATRIOVENTRICULAR CONDUCTION; AUTOIMMUNE DISEASE; BRADYCARDIA; CLINICAL FEATURE; COMPLETE HEART BLOCK; CONGESTIVE CARDIOMYOPATHY; CONNECTIVE TISSUE DISEASE; ENDOCARDIAL FIBROELASTOSIS; FETOTOXICITY; FETUS ELECTROCARDIOGRAPHY; FETUS HEART RATE; FETUS HYDROPS; HEART ARRHYTHMIA; HEART FAILURE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INFLAMMATION; LUPUS ERYTHEMATOSUS; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; OLIGOHYDRAMNIOS; PATHOGENESIS; PATIENT MONITORING; PHAGOCYTOSIS; PLACENTAL TRANSFER; PLASMAPHERESIS; PLEURA EFFUSION; PREMATURE LABOR; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SINUS BRADYCARDIA; SJOEGREN SYNDROME; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYCARDIA;

AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; CONNECTIVE TISSUE DISEASES; FEMALE; HEART BLOCK; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PACEMAKER, ARTIFICIAL; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 33748441889     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.11.115     Document Type: Review

References (58)

1. Michaelsson M., and Engle M.A. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 4 (1972) 85-98
2. Morquio L. Sur une maladie infantile et familiale characterise'e par des modifications permanentes du pouls des attaques syncopales et eptileptiformes et la mort subite. Arch Med Inf 4 (1901) 467-469
3. Jaeggi E.T., Hornberger L.K., Smallhorn J.F., and Fouron J.C. Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet Gynecol 26 (2005) 16-21
4. Berg C., Geipel A., Kohl T., et al. Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 26 (2005) 4-15
5. Hull D., Binns B.A.O., and Joyce D. Congenital heart block and widespread fibrosis due to maternal erythematosus. Arch Dis Child 41 (1966) 688-690
6. Laxer R.M., Roberts E.A., Gross K.R., et al. Liver disease in neonatal lupus erythematosus. J Pediatr 116 (1990) 238-242
7. Watson R., Kang J.E., May M., Hudak M., Kickler T., and Provost T.T. Thrombocytopenia in the neonatal lupus syndrome. Arch Dermatol 124 (1988) 560-563
8. Buyon J.P., Waltuck J., Kleinman C., et al. In utero identification and therapy of congenital heart block. Lupus 4 (1995) 116-121
9. Waltuck J., and Buyon J.P. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 120 (1994) 544-551
10. Buyon J.P. Congenital complete heart block (review). Lupus 2 (1993) 291-295
11. Eronen M., Siren M.K., Ekblad H., et al. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 106 (2000) 86-91
12. Buyon J., Hiebert R., Copel J., et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31 (1998) 1658-1666
13. Cimaz R., Airoldi M.L., Careddu P., et al. Transient neonatal bradycardia without heart block associated with anti-Ro antibodies. Lupus 6 (1997) 487-488
14. Brucato A., Cimaz R., Catelli L., and Meroni P.L. Anti-Ro associated sinus bradycardia in new-borns. Circulation 102 (2000) E88-9
15. Cimaz R., Stramba-Badiale M., Brucato A., Catelli L., Panzeri P., and Meroni P.L. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 43 (2000) 1049-1053
16. Cimaz R., Meroni P.L., Brucato A., et al. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal auto antibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum 48 (2003) 266-268
17. Moak J.P., Barron K.S., Hougen T.J., et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 37 (2001) 238-242
18. Nield L.E., Silverman E.D., Taylor G.P., et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 105 (2002) 843-848
19. Michaelsson M., Jonzon A., and Riesenfeld T. Isolated congenital complete atrioventricular block in adult life: a prospective study. Circulation 92 (1995) 442-449
20. Buyon J.P., and Winchester R.J. Complete congenital block: a model of passively acquired autoimmunity. Arthritis Rheum 33 (1990) 609-614
21. Buyon J.P. Neonatal lupus. Curr Opin Rheumatol 8 (1996) 485-490
22. Wang D., Buyon J.P., Zhu W., et al. Defining a novel 75-kDa phosphoprotein associated with SS-A/Ro and identification of distinct human autoantibodies. J Clin Invest 104 (1999) 1265-1275
23. Ho S.Y., Esscher E., Anderson R.H., and Michaelsson M. Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol 58 (1986) 291-294
24. Anderson R.H., Wenick A.C.G., Losekoot T.G., and Becker A.E. Congenitally complete heart block. Circulation 56 (1977) 90-98
25. Michaelsson M. Congenital complete atrioventricular block. Prog Pediatr Cardiol 4 (1995) 1-7
26. Buyon J.P., Waltuck J., Caldwell K., et al. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block. J Rheumatol 21 (1994) 1943-1950
27. Litsey S.E., Noonan J.A., O'Connor W.N., Cottrill C.M., and Mitchell B. Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med 312 (1985) 98-100
28. Fesslova V., Mannarino S., Salice P., et al. Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets. Lupus 12 (2003) 775-778
29. Miranda M.E., Tseng C.E., Rashbaum W., et al. Accessibility of SSA/Ro and SSB/La antigens to maternal auto antibodies in apoptotic human fetal cardiac myocytes. J Immunol 161 (1998) 5061-5069
30. Miranda-Carus M.E., Askanase A.D., Clancy R.M., et al. Anti-SSA/Ro and anti-SSB/La auto antibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 165 (2000) 5345-5351
31. Mohamed B., Long C., et al. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res 80 (1997) 354-362
32. Keli H., Yongxia Q., Yuankun Y., and Mohamed B. Functional basis of sinus bradycardia in congenital heart block. Circ Res 94 (2004) e32-e38
33. Rosenthal D., Friedman D.M., Buyon J., and Dubin A. Validation of the Doppler PR interval in the fetus. J Am Soc Echocardiogr 15 (2002) 1029-1030
34. Raboisson M.J., Fouron J.C., Sonesson S.E., Nyman M., Proulx F., and Gamache S. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies. J Am Soc Echocardiogr 18 4 (Apr 2005) 375-380
35. Fouron J.C., Proulx F., Miro J., and Gosselin J. Doppler and M-Mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol 96 (2000) 732-736
36. Julkunen H., Miettinen A., Walle T.K., Chan E.K., and Eronen M. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study. J Rheumatol 31 1 (Jan 2004) 183-189
37. Groves A.M.M., Allan L.D., and Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 75 (1996) 190-194
38. Levy A.M., Camm A.J., and Keane J.F. Multiple arrhythmias detected during nocturnal monitoring in patients with congenital complete heart block. Circulation 55 (1977) 247-253
39. Winkler R.B., Freed M.D., and Nadas A. Exercise-induced ventricular ectopy in children and young adults with complete heart block. Am Heart J 99 (1980) 87-92
40. Esscher E., and Michaelsson M. Q-T interval in congenital complete heart block. Pediatr Cardiol 4 (1983) 121-124
41. Solti F., Szatmáry L., Vecsey T., Rényi-Vámos F., and Bodor E. Congenital complete heart block associated with QT prolongation. Eur Heart J 13 (1992) 1080-1083
42. McCune A.B., Weston W.L., and Lee LA. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med 106 (1987) 518-523
43. Brucato A., Cimaz R., and Stramba-Badiale M. Neonatal lupus. Clin Rev Allergy Immunol 3 (2002) 279-299
44. Buyon J.P., and Clancy R.M. Maternal auto antibodies and congenital heart block. Mediators, markers, and therapeutic approach. Semin Arthritis Rheum 33 (2003) 140-154
45. Costedoat-Chalumeau N., Amoura Z., Le Thi Hong D., et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 63 (2003) 1010-1012
46. Breur J.M.P.J., Visser G.H.A., Kruize A.A., Stoutenbeek P., and Meijboom E.J. Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature. Ultrasound Obstet Gynecol 24 (2004) 467-472
47. Jaeggi E.T., Fouron J.C., Silverman E.D., Ryan G., Smallhorn J., and Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110 12 (2004) 1542-1548
48. Groves A.M.M., Allan L.D., and Rosenthal E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 92 (1995) 3394-3396
49. Schmidt K.G., Ulmer H.E., Silverman N.H., Kleinman C.S., and Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 17 (1991) 1360-1366
50. Carpenter R.J., Strasburger J.F., Garson A., Smith R.T., Deter R.L., and Engelhardt HT. Fetal ventricular pacing for hydrops secondary to complete atrioventricular block. J Am Coll Cardiol 8 (1986) 1434-1436
51. Donofrio M.T., Gullquist S.D., Mehta I.D., and Moskowitz W.B. Congenital complete heart block: fetal management protocol, review of the literature, and report of the smallest successful pacemaker implantation. J Perinatol 24 2 (2004 [Feb]) 112-117
52. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 40 9 (2002 [Nov 6]) 1703-1719
53. Maginot K.R., Mathewson J.W., and Bichell D.P. Application of pacing strategies in neonates and infants. Prog Pediatr Cardiol 11 (2000) 65-75
54. Friedman R.A., Fenrich A.C., and Kertesz N.J. Congenital complete atrioventricular block. PACE 24 (2001)
55. Serwer G.A. Permanent pacing in children: acute lead implantation and long term follow-up. Prog Pediatr Cardiol 4 (1995) 31-41
56. Rao V., Williams W.G., and Hamilton R.H. Trends in pediatric cardiac pacing. Can J Cardiol 11 (1995) 993-999
57. Karpawich P.P., Perry B.L., Farooki Z.Q., et al. Pacing in children and young adults with nonsurgical atrioventricular block: comparison of single-rate ventricular and dual-chamber modes. Am Heart J 113 (1987) 316-321
58. Thambo J.B., Bordachar P., et al. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation 110 (2004) 3766-3772